Three new transplant surgeons expand transplant services and research at Miami Valley Hospital
Three new transplant surgeons have joined the Miami Valley Hospital (MVH) Transplant Center and the faculty of the Boonshoft School of Medicine.
R. Brian Stevens, M.D., Ph.D., FACS, will serve as the new surgical director of the MVH transplant program and professor of surgery in the Boonshoft School of Medicine. Lucile Wrenshall, M.D., Ph.D., FACS, is the new director of the living donor kidney program at MVH and professor of surgery, and Tamer Malik, M.D., FACS, has joined the program as a transplant surgeon and assistant professor of surgery. The new physicians join Augustus Eduafo, M.D., clinical associate professor of internal medicine, and William Rundell Jr., M.D., clinical professor of surgery.
Stevens and Wrenshall trained at the University of Minnesota Medical Center, home to one of the oldest and most successful transplant centers in the world. Malik completed a cardiovascular research fellowship at Beth Israel Deaconess Medical Center, Harvard University, Boston, and a fellowship in abdominal solid organ transplant surgery at the University of Nebraska Medical Center. All three are fellowship trained in transplant surgery and fellows of the American College of Surgeons, the most rigorous accreditation possible for surgeons.
Prior to coming to Dayton, Stevens and Wrenshall practiced at the University of Nebraska Medical Center where Dr. Stevens served as director of the Kidney and Pancreas Transplant Program and director of the Islet and Cell Transplant Program. Malik served as a surgeon and assistant professor of surgery, transplant division, at the University of Kansas Medical Center.
In addition to kidney transplantation, the team is trained in hepatobiliary and pancreatic surgery. They can provide state-of-the-art care for patients with diseases related to the liver, bile duct, and gallbladder.
“Our intent is not simply to do transplants,” said Stevens, “but to make available to the people in this region the best possible transplant care available in the nation if not the world. And to do it in a very personal way.”
The new team will also focus on cutting-edge research in the transplant field. Joined by their research teams, who also made the move to Dayton, the physicians will continue to expand their basic and clinical research into new treatments to minimize the need for aggressive immunosuppression in transplant patients. They are researching new ways to “trick” the patient’s immune system into accepting the new kidney as their own so that it is not rejected.
“There’s always been a very high quality clinical transplant program here,” said Stevens. “Now we’re going to expand upon it and build a world-class transplant center right here in the Dayton region.”